News & Politics πŸ‡ΊπŸ‡Έ United States

Michael Soroka's 2026 MLB Season: Injury Updates and Contract Status

76 reads ·
Quick Answer: Michael Soroka signed with the White Sox in 2026 after missing most of 2024-2025 with injuries. He's working to rebuild his career following multiple Achilles surgeries.

Current Team Status and Contract Details

Michael Soroka signed a one-year, $9 million contract with the Chicago White Sox in February 2026, marking a fresh start after his injury-plagued tenure with the Atlanta Braves. The 29-year-old right-handed pitcher chose Chicago over several competing offers, including interest from the Texas Rangers and Detroit Tigers. His deal includes performance incentives that could push the total value to $12 million if he reaches specific innings and wins thresholds.

Injury History and Recovery Timeline

Soroka's career has been derailed by multiple Achilles tendon injuries, beginning with his initial rupture in August 2020 during a game against the New York Mets. He underwent his third Achilles surgery in March 2024, causing him to miss the entire 2024 season and most of spring training 2025. The Canadian-born pitcher made only 12 starts across 2021-2025, accumulating just 77 innings pitched during what should have been his prime years.

Performance Outlook for 2026 Season

Early reports from White Sox spring training indicate Soroka's velocity has returned to pre-injury levels, sitting consistently at 93-95 mph with his four-seam fastball. His slider and changeup command appear sharp, though team medical staff are monitoring his workload carefully with a 140-innings limit for 2026. Soroka posted a 6.21 ERA across 13 starts in 2025, but his peripheral statistics suggested better underlying performance than his surface numbers indicated.

Fantasy Baseball and Betting Considerations

Fantasy baseball platforms have Soroka ranked as the 85th starting pitcher entering 2026, reflecting cautious optimism about his health and effectiveness. His current ADP (Average Draft Position) sits around pick 180 in 12-team leagues, making him a potential late-round value pick if he stays healthy. DraftKings and FanDuel have set his season win total at 8.5 games, with over/under odds favoring the under due to his injury concerns and the White Sox's projected struggles.

White Sox Rotation Role and Expectations

The White Sox acquired Soroka to serve as their third or fourth starter, slotting behind Dylan Cease and Garrett Crochet in their projected 2026 rotation. Chicago's rebuilding timeline aligns with Soroka's need to prove his durability, creating a mutually beneficial situation for both parties. The organization has invested heavily in biomechanics and sports science technology, hoping to keep Soroka healthy while he rebuilds his market value for future contracts.

Long-term Career Prospects

If Soroka can complete a full season in 2026, he positions himself for a significant multi-year contract worth potentially $60-80 million over three to four years. His age-27 and 28 seasons were essentially lost to injury, but his pre-injury track record includes a 2019 All-Star appearance and 2.68 ERA across his first two full seasons. Several teams, including the Toronto Blue Jays and San Francisco Giants, are reportedly monitoring his progress with interest for potential 2027 pursuits.

Related Questions

When will Michael Soroka return to full health? Medical experts project mid-2026 as his target for complete recovery, though his workload will remain carefully managed throughout the season.

What teams were interested in signing Michael Soroka? The Rangers, Tigers, Blue Jays, and Marlins all made offers before he chose the White Sox's one-year prove-it contract. (Related: Alix Earle: Social Media Star's Rise to Fame and Business Empire in 2026)

How much is Michael Soroka making in 2026? His base salary is $9 million with incentives that could reach $12 million total, representing a significant pay cut from his pre-injury earning potential. (Related: Roberto De Zerbi: Brighton Manager's Tactical Revolution and Future Prospects in 2026)